Article
Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma (Review)
20 Mar 2018
Abstract excerpt
Despite the development of standard therapies, including surgery, radiotherapy and chemotherapy, survival rates for head and neck squamous cell carcinoma (HNSCC) have not changed significantly over the past three decades. Complete recovery is achieved in <50% of patients. The treatment of advanced HNSCC frequently requires multimodality therapy and involves significant toxicity. The promising, novel treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
